Venue Details:

Description:

GLP-1 Agonists: Risks & Benefits

GLP-1 agonists have transformed the management of type 2 diabetes and obesity, offering impressive weight loss and metabolic benefits. But are these medications a long-term solution, or are they simply masking the underlying causes of metabolic disease? This presentation provides an evidence-based overview of how GLP-1 agonists work, their clinical benefits, potential risks, and emerging concerns. We will discuss appropriate patient selection, strategies to minimise adverse effects, and the importance of combining medication with sustainable lifestyle interventions. The session will also explore an integrative approach that uses GLP-1 agonists as a bridge toward restoring long-term metabolic health rather than creating lifelong dependency. Practical case studies and clinical pearls will help practitioners confidently navigate this rapidly evolving area of medicine.

Topic: